Why the study?
Does nisoldipine coat-core improve blood pressure and heart rate response in patients with mild-to-moderate hypertension?
Does nisoldipine coat-core improve blood pressure and heart rate response in patients with mild-to-moderate hypertension?
Nisoldipine coat-core effectively lowers blood pressure in mild-to-moderate hypertension while maintaining a neutral heart rate profile, offering potential advantages over short-acting calcium channel blockers.
Answers are grounded in this paper and cite their sources.
Supports nisoldipine coat-core for 24-hour BP control with neutral heart rate; hypothesis-generating from Level 5 review, randomized trials needed.
Nisoldipine coat-core (nisoldipine CC), an extended-release once-daily formulation, is an effective treatment for mild-to-moderate hypertension, providing sustained blood pressure control over the 24-hour dosing interval. Nisoldipine CC is highly vascular selective. It causes neither reflex tachycardia nor symptomatic bradycardia; it lacks significant negative inotropy at therapeutic doses; and it does not affect circadian variation in blood pressure or heart rate. Data suggest that the lack of reflex sympathetic activation in response to the blood pressure-lowering effect of nisoldipine CC is due to the smooth onset of action of nisoldipine CC, causing resetting of the baroflex. The neutral heart rate profile of nisoldipine CC confers potential therapeutic advantages over several other calcium channel blockers, in particular, the short-acting agents, in the treatment of hypertension.
No takes yet. Share an insight, caveat, or question.
Faı̈ez Zannad (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: